Dr. Martin Bert Leon
“Fortune Teller!” Shaping the Future
Dr. Martin Bert Leon (USA) is a Professor of Medicine at Columbia University Irving Medical Center and the Founder of the Cardiovascular Research Foundation (CRF) and Transcatheter Cardiovascular Therapeutics (TCT), the world’s leading interventional cardiovascular meeting. A visionary thought leader, he has significantly influenced the development of interventional cardiovascular devices and drug therapies. Dr. Leon has been pivotal in over 75 clinical trials, including landmark studies like STRESS, STARS, Gamma-One, SIRIUS, ENDEAVOR, and the PARTNER trials, which revolutionized the treatment of aortic stenosis through TAVR. With over 2,000 publications and more than 10,000 interventional procedures to his credit, he has made an unparalleled impact on the field. His collaboration also helped launch TCTAP in 2005. Among his many accolades are the “Master of the Masters” Award at TCTAP in 2012 and the ACC Lifetime Achievement Award in 2019. A memory that stands out is his prediction, made a decade ago, that TAVR would become the mainstream therapy for nearly all aortic stenosis patients. Today, that vision is a reality, proving him to be a true visionary.
It inspires intelligence. He is articulated, he is visionary. (Patrick W. Serruys) Your ability to educate, mentor, and envision what the future shows and will has been your incredible talent. Your contribution to the field is immense, so you’re a master there. (Roxana Mehran) He is a very positive person. He spreads positive energy. TCTAP, he has been a supporter, a friend for many years, and he has been a very consistent factor. Hopefully we have many, many more years to cooperate. (Eberhard Grube) Martin is not only an outstanding interventional cardiologist, a physician scientist, but also an innovator Martin as a founder and director has greatly promoted the advances of interventional cardiology in the whole world. (Runlin Gao) If you had chosen a field other than interventional cardiology, there would have been no CRF, no TCT, and probably no Angioplasty Summit-TCT Asia pacific. (Gary S. Mintz) No one has meant more to the field of interventional cardiology than you have. (Gregg W. Stone)
Dr. Martin Bert Leon (USA) is a Professor of Medicine at Columbia University Irving Medical Center and the Founder of the Cardiovascular Research Foundation (CRF) and Transcatheter Cardiovascular Therapeutics (TCT), the world’s leading interventional cardiovascular meeting. A visionary thought leader, he has significantly influenced the development of interventional cardiovascular devices and drug therapies. Dr. Leon has been pivotal in over 75 clinical trials, including landmark studies like STRESS, STARS, Gamma-One, SIRIUS, ENDEAVOR, and the PARTNER trials, which revolutionized the treatment of aortic stenosis through TAVR. With over 2,000 publications and more than 10,000 interventional procedures to his credit, he has made an unparalleled impact on the field. His collaboration also helped launch TCTAP in 2005. Among his many accolades are the “Master of the Masters” Award at TCTAP in 2012 and the ACC Lifetime Achievement Award in 2019. A memory that stands out is his prediction, made a decade ago, that TAVR would become the mainstream therapy for nearly all aortic stenosis patients. Today, that vision is a reality, proving him to be a true visionary.
It inspires intelligence. He is articulated, he is visionary. (Patrick W. Serruys) Your ability to educate, mentor, and envision what the future shows and will has been your incredible talent. Your contribution to the field is immense, so you’re a master there. (Roxana Mehran) He is a very positive person. He spreads positive energy. TCTAP, he has been a supporter, a friend for many years, and he has been a very consistent factor. Hopefully we have many, many more years to cooperate. (Eberhard Grube) Martin is not only an outstanding interventional cardiologist, a physician scientist, but also an innovator Martin as a founder and director has greatly promoted the advances of interventional cardiology in the whole world. (Runlin Gao) If you had chosen a field other than interventional cardiology, there would have been no CRF, no TCT, and probably no Angioplasty Summit-TCT Asia pacific. (Gary S. Mintz) No one has meant more to the field of interventional cardiology than you have. (Gregg W. Stone)